Related Experiment Videos
Peptide immunotherapy
1Department of Allergy and Clinical Immunology, Faculty of Medicine, Imperial College, South Kensington, London SW7 2AZ, UK. m.larche@imperial.ac.uk
Immunology and Allergy Clinics of North America
|May 17, 2006
Summary
Synthetic peptides can induce antigen-specific tolerance for autoimmune and allergic diseases. This peptide therapy approach shows promise for safe and effective disease modification.
Area of Science:
- Immunology
- Allergy and Immunology
- Autoimmunity
Background:
- Synthetic peptides targeting T-cell epitopes are used to induce antigen-specific tolerance.
- This approach has been explored in both experimental models and clinical settings.
Purpose of the Study:
- To investigate the potential of synthetic peptides in inducing antigen-specific tolerance.
- To evaluate the efficacy and safety of peptide therapy for autoimmune and allergic diseases.
Main Methods:
- Administration of synthetic peptides representing T-cell epitopes of allergens and autoantigens.
- Induction of antigen-specific tolerance in vivo through oral or injection delivery routes.
Main Results:
- Reduced reactivity to specific antigens was observed following peptide administration.
- Induction of T cells with a regulatory phenotype was associated with peptide therapy.
Conclusions:
- Peptide therapy offers a promising strategy for disease modification in allergic and autoimmune conditions.
- This approach demonstrates potential for being safe, effective, and economically viable.